Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
KalVista Pharmaceuticals, Inc. (KALV)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
17 Feb 2024
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
211,203
-10%
24,888
$14.11
$351,289.16
SELL
17 Feb 2024
Audhya Paul K.
CHIEF MEDICAL OFFICER, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
52,886
-21%
14,295
$14.12
$201,773.92
SELL
17 Feb 2024
Palleiko Benjamin L
CFO, CBO, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
187,315
-10%
22,802
$14.11
$321,845.70
SELL
17 Feb 2024
Yea Christopher
CHIEF DEVELOPMENT OFFICER, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
72,895
-14%
12,053
$14.11
$170,124.48
SELL
17 Feb 2024
Feener Edward P.
CHIEF SCIENTIFIC OFFICER, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,048
-25%
28,288
$14.07
$397,929.00
SELL
14 Feb 2024
Feener Edward P.
CHIEF SCIENTIFIC OFFICER, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
71,657
-28%
28,171
$15.01
$422,827.00
SELL
14 Feb 2024
Yea Christopher
CHIEF DEVELOPMENT OFFICER, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
66,160
-37%
39,886
$15.01
$598,660.94
SELL
14 Feb 2024
Palleiko Benjamin L
CFO, CBO, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
159,088
-20%
40,855
$15.01
$613,204.94
SELL
14 Feb 2024
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
181,676
-24%
58,356
$15.01
$875,882.75
BUY
6 Feb 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,824,731
+1%
86,048
$14.62
$1,257,828.80
SELL
1 Feb 2024
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
118,232
-7%
10,000
$16.22
$162,198.45
BUY
30 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,738,683
+1%
88,099
$14.47
$1,274,792.50
BUY
25 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,650,584
+2%
91,804
$14.05
$1,289,802.40
BUY
22 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,558,780
+2%
99,129
$12.53
$1,241,684.50
BUY
17 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,459,651
+3%
143,605
$12.55
$1,801,601.80
SELL
11 Jan 2024
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
39,828
-36%
22,679
$13.03
$295,514.20
BUY
11 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,316,046
+0%
26,246
$12.72
$333,779.22
SELL
8 Jan 2024
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
62,507
-21%
17,321
$13.01
$225,300.42
BUY
8 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,289,800
+3%
137,700
$12.54
$1,726,456.90
BUY
3 Jan 2024
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,152,100
+1%
59,369
$12.14
$720,543.00
SELL
27 Dec 2023
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
127,532
-19%
30,000
$12.02
$360,453.00
BUY
27 Dec 2023
Venrock Healthcare Capital Partners III, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
4,092,731
+14%
519,017
$12.46
$6,465,650.00
SELL
11 Sep 2023
Cha Albert
Director
KalVista Pharmaceuticals, Inc.
(KALV)
0
-100%
18,000
$10.50
$189,050.40
SELL
17 Aug 2023
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
41,662
-14%
7,142
$10.73
$76,624.38
SELL
17 Aug 2023
Palleiko Benjamin L
President, CFO, CBO & Sec'y, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
95,254
-12%
13,067
$10.73
$140,191.92
SELL
17 Aug 2023
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
146,756
-9%
14,876
$10.73
$159,601.62
SELL
17 Aug 2023
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
73,289
-6%
4,976
$10.73
$53,386.01
SELL
17 Aug 2023
Audhya Paul K.
Chief Medical Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
26,023
-23%
8,020
$10.73
$86,044.98
SELL
17 Feb 2023
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
120,927
-5%
6,700
$7.66
$51,322.00
SELL
17 Feb 2023
Audhya Paul K.
Chief Medical Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
9,347
-26%
3,412
$7.66
$26,135.92
SELL
17 Feb 2023
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
64,352
-3%
2,228
$7.66
$17,066.48
SELL
17 Feb 2023
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
35,709
-7%
2,727
$7.66
$20,888.82
SELL
17 Feb 2023
Palleiko Benjamin L
President, CFO, CBO & Sec'y, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
72,799
-6%
4,954
$7.66
$37,947.64
SELL
11 Jan 2023
Audhya Paul K.
Chief Medical Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
13,014
-17%
2,780
$10.14
$28,201.43
SELL
11 Jan 2023
Palleiko Benjamin L
President, CFO, CBO & Sec'y, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
78,126
-4%
4,037
$10.14
$40,952.94
SELL
11 Jan 2023
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
66,771
-2%
1,786
$10.14
$18,117.90
SELL
11 Jan 2023
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
128,050
-4%
5,627
$10.14
$57,082.54
SELL
11 Jan 2023
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
37,310
-6%
2,604
$10.14
$26,416.02
BUY
12 Dec 2022
Christopher L. Jacobs
Congressman (House)
KalVista Pharmaceuticals, Inc.
(KALV)
N/A
N/A
N/A
$1,001 - $15,000
SELL
21 Nov 2022
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
34,232
-3%
1,139
$5.44
$6,196.16
SELL
17 Nov 2022
Audhya Paul K.
Chief Medical Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
5,946
-10%
722
$5.44
$3,927.68
SELL
17 Nov 2022
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
114,878
-1%
1,785
$5.44
$9,710.40
SELL
17 Nov 2022
Palleiko Benjamin L
CFO, CBO & Secretary, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
68,390
-1%
722
$5.44
$3,927.68
SELL
17 Nov 2022
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
62,376
-0%
530
$5.44
$2,883.20
SELL
2 Sep 2022
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
110,858
-1%
1,320
$17.01
$22,457.69
SELL
17 Aug 2022
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
112,178
-1%
1,797
$14.96
$26,890.49
SELL
17 Aug 2022
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
61,132
-0%
532
$14.96
$7,959.73
SELL
17 Aug 2022
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
33,597
-3%
1,145
$14.96
$17,130.00
SELL
17 Aug 2022
Palleiko Benjamin L
CFO, CBO & Secretary, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
66,693
-1%
725
$14.96
$10,846.58
SELL
17 Aug 2022
Audhya Paul K.
Chief Medical Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
1,693
-29%
725
$14.96
$10,847.09
SELL
9 Mar 2022
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
114,670
-8%
10,000
$17.07
$170,693.00
SELL
1 Nov 2021
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
2,234
-72%
6,000
$18.07
$108,423.60
SELL
1 Nov 2021
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
32,969
-13%
5,000
$18.07
$90,328.00
SELL
1 Oct 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
124,670
-7%
10,000
$17.18
$171,840.98
SELL
2 Aug 2021
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
37,969
-11%
5,000
$20.52
$102,578.50
SELL
2 Aug 2021
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
8,234
-42%
6,000
$20.52
$123,133.81
SELL
1 Jul 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
140,320
-6%
10,000
$24.15
$241,476.95
SELL
17 Jun 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
144,670
-0%
1,067
$30.04
$32,050.55
SELL
9 Jun 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
145,737
-5%
8,933
$30.05
$268,480.40
SELL
1 Jun 2021
Smith Michael David
Senior VP, Development, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
0
-100%
7,500
$26.83
$201,221.25
SELL
1 Jun 2021
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
15,296
-68%
34,000
$26.72
$908,360.70
SELL
3 May 2021
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
42,969
-10%
5,000
$24.84
$124,196.50
SELL
3 May 2021
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
54,234
-9%
6,000
$24.84
$149,050.80
SELL
28 Apr 2021
Smith Michael David
Senior VP, Development, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
0
-100%
10,014
$25.76
$257,982.67
SELL
27 Apr 2021
Maetzel Andreas
Senior Vice President, Medical, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
0
-100%
88,030
$25.28
$2,225,736.20
SELL
1 Apr 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
168,720
-5%
10,000
$27.44
$274,436.22
SELL
23 Feb 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
178,920
-5%
10,000
$33.55
$335,538.30
SELL
23 Feb 2021
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
62,169
-19%
15,000
$33.59
$503,877.30
SELL
23 Feb 2021
Palleiko Benjamin L
CFO, CBO & Secretary, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
93,642
-24%
29,642
$33.59
$995,561.80
SELL
23 Feb 2021
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
83,946
-26%
31,000
$33.60
$1,041,642.40
SELL
4 Jan 2021
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
186,234
-5%
10,000
$18.19
$181,904.14
SELL
30 Dec 2020
Palleiko Benjamin L
CFO, CBO & Secretary, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
32,500
-1%
358
$20.04
$7,174.79
SELL
2 Nov 2020
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
72,734
-7%
6,000
$17.14
$102,811.80
BUY
30 Oct 2020
Cha Albert
Director
KalVista Pharmaceuticals, Inc.
(KALV)
1,090,748
+11%
115,686
$17.24
$1,994,067.80
SELL
29 Oct 2020
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
62,969
-7%
5,000
$17.48
$87,394.00
SELL
20 Oct 2020
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
212,165
-15%
38,539
$17.98
$693,025.10
SELL
20 Oct 2020
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
70,513
-16%
13,986
$17.82
$249,167.39
SELL
20 Oct 2020
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
84,141
-16%
16,907
$17.92
$303,018.60
SELL
16 Oct 2020
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
81,955
-1%
914
$17.00
$15,539.28
SELL
16 Oct 2020
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
95,641
-1%
993
$17.00
$16,881.00
SELL
29 Apr 2020
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
236,959
-0%
1,261
$17.01
$21,444.06
SELL
5 Feb 2020
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
238,220
-0%
200
$17.05
$3,410.00
SELL
5 Feb 2020
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,869
-0%
100
$17.10
$1,710.00
SELL
5 Feb 2020
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
96,634
-0%
100
$17.11
$1,711.00
SELL
20 Dec 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
238,420
-0%
2,300
$17.02
$39,150.37
SELL
20 Dec 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,969
-3%
2,646
$17.02
$45,025.13
SELL
12 Dec 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
240,720
-3%
7,700
$17.06
$131,352.30
SELL
12 Dec 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,969
-5%
4,709
$17.05
$80,269.34
BUY
26 Sep 2019
SOLAND DANIEL B
Director
KalVista Pharmaceuticals, Inc.
(KALV)
10,000
+100%
10,000
$11.87
$118,749.98
BUY
26 Jul 2019
Cha Albert
Director
KalVista Pharmaceuticals, Inc.
(KALV)
1,022,493
+5%
56,367
$16.99
$957,737.06
SELL
22 Jul 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,969
-8%
7,355
$18.35
$134,929.69
SELL
22 Jul 2019
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
96,734
-3%
3,300
$18.62
$61,443.01
BUY
17 Jul 2019
Cha Albert
Director
KalVista Pharmaceuticals, Inc.
(KALV)
114,871
+114%
61,280
$17.79
$1,090,295.80
SELL
15 Jul 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
248,510
-3%
10,000
$17.04
$170,407.02
SELL
22 Apr 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
83,969
-8%
7,355
$26.04
$191,529.84
SELL
18 Apr 2019
Palleiko Benjamin L
CBO, CFO and Secretary, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
32,500
-8%
3,073
$25.70
$78,976.41
SELL
17 Apr 2019
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
100,950
-3%
4,000
$24.92
$99,666.27
SELL
15 Apr 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
258,810
-3%
10,000
$24.80
$247,957.72
SELL
8 Apr 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,672,105
-2%
50,000
$29.20
$1,460,145.00
SELL
5 Apr 2019
Maetzel Andreas
Senior Vice President Medical, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
0
-100%
5,000
$30.00
$150,011.00
SELL
29 Mar 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,720,725
-5%
97,074
$28.03
$2,720,896.80
SELL
26 Mar 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,815,119
-6%
124,675
$28.84
$3,596,032.20
SELL
18 Mar 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,936,352
-11%
262,470
$26.70
$7,007,949.00
SELL
18 Mar 2019
Venrock Healthcare Capital Partners II, L.P.
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,544,112
-24%
500,000
$28.75
$14,375,000.00
SELL
14 Mar 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
268,510
-1%
3,000
$30.16
$90,483.90
SELL
4 Mar 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,191,576
-3%
75,710
$22.96
$1,738,476.00
SELL
19 Feb 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,265,196
-8%
214,198
$20.55
$4,401,353.50
SELL
25 Jan 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,969
-6%
5,453
$17.06
$93,015.09
SELL
22 Jan 2019
Yea Christopher
Chief Development Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
82,969
-2%
1,902
$17.01
$32,343.93
SELL
16 Jan 2019
Feener Edward P.
Chief Scientific Officer, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
106,334
-3%
4,000
$19.55
$78,209.88
SELL
14 Jan 2019
Crockett Thomas Andrew
CEO, Director, Officer
KalVista Pharmaceuticals, Inc.
(KALV)
272,411
-3%
10,000
$19.33
$193,328.30
SELL
3 Jan 2019
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,473,481
-0%
4,299
$20.25
$87,072.88
SELL
28 Dec 2018
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,477,661
-1%
29,352
$20.01
$587,242.50
SELL
19 Dec 2018
SVLSF IV, LLC
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,506,202
-0%
2,136
$20.02
$42,758.45
BUY
10 Sep 2018
ORONSKY ARNOLD L
Director
KalVista Pharmaceuticals, Inc.
(KALV)
388,766
+17%
58,824
$17.00
$1,000,008.00
BUY
10 Sep 2018
Cha Albert
Director
KalVista Pharmaceuticals, Inc.
(KALV)
1,359,149
+352%
1,058,824
$17.00
$18,000,008.00
BUY
12 Oct 2017
ALDRICH RICHARD
Director
KalVista Pharmaceuticals, Inc.
(KALV)
934,484
+152%
565,065
$8.61
$4,866,961.50
BUY
12 Oct 2017
RA CAPITAL MANAGEMENT, LLC
Director, 10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,441,070
+143%
850,000
$8.50
$7,225,000.00
BUY
12 Oct 2017
Shah Rajeev M.
Director, 10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,441,070
+143%
850,000
$8.50
$7,225,000.00
SELL
10 Oct 2017
Novo Holdings A/S
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
1,726,000
-61%
2,725,283
$9.64
$26,271,182.00
SELL
13 Sep 2017
Novo Holdings A/S
10% Owner
KalVista Pharmaceuticals, Inc.
(KALV)
2,725,283
-6%
176,647
$7.21
$1,273,979.80
Home